Director, Value Access & Strategy

Director, Value Access & Strategy

United States - California - Santa Monica, Market Access & Health Economics, Regular

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next.

We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.

In this position, you will be a critical GVA partner for two key launches of our potentially best in class CAR T in RR-MM:

• Execute the 4L+ iMMagine-1 Global Launch – develop the global market access strategy to support the ex‑US launch together with the key commercialization functions of Marketing, Medical Affairs, Technical Operations and the regional Access team.
• Prepare the 2L+ iMMagine-3 Global Launch – partner with regional (US, ACE, ICR) teams to optimize the access and reimbursement strategies for anito‑cel in 2L RR‑MM. Work closely with HEOR/RWE to ensure the production of compelling payer value evidence tools for rapid access.

• Key Market Access representative and lead in the Global Brand Team and Join‑GBT for anito‑cel.
• Partner with the Global and Regional functions of Value Access, HEOR/RWE and commercial to ensure seamless execution of the Access Strategy.
• Analyze future market access trends and competitor entry; advise the GBT/PT on access‑relevant endpoints, study designs, and magnitude of effect to achieve reimbursement, focusing on Kite’s major markets of US, Australia, Canada, EU‑5 (ACE‑7) and Japan.
• Provide input into clinical development programs to capture value, align to what is meaningful to patients, support a differentiated target product profile (TPP) and ensure the right evidence is collected to support future reimbursement and pricing negotiations.
• Accountable for the market access and payer perspective to be reflected in cross‑functional strategies (product development, medical affairs, regulatory affairs, commercial).
• Partner with Health Economics Outcomes Research (HEOR), Real‑World Evidence (RWE) and Global Marketing to ensure meaningful target product profiles are developed and evidence plans are optimized to support reimbursement.
• Identify global HEOR evidence requirements and gaps; coordinate with HEOR to develop studies, models, and resources to support value demonstration and product differentiation for assigned indication(s).

• 12+ years’ experience with a BS/BA (or equivalent).
• 10+ years’ experience with an MS/MA or MBA (or equivalent).

• Previous experience supporting product launches, ideally in oncology.
• Demonstrated experience in a healthcare environment, preferably the pharmaceutical industry or related consulting services.
• Extensive understanding of the global hematology/ multiple myeloma market access landscape, cell therapy business and healthcare system dynamics.
• Detailed knowledge of payer systems, pricing and reimbursement mechanisms, decision‑makers and payer stakeholder behavior for relevant markets (US, EU‑5, Japan).
• Knowledge of HTA assessments including value frameworks, methodologies, trends and drivers in relevant markets.
• Ability to guide the development plan and lead inputs based on payer requirements and market access trends.
• Excellent communication skills and experience in presenting at senior committees.
• Ability to collaborate successfully across multiple cultures and time‑zones.
• Demonstrated leadership in cross‑functional teams.

• Create Inclusion – knowing the business value of diverse teams, modeling inclusion, and…